ONTOLOGY REPORT - ANNOTATIONS
| Term: | 2-acetamidofluorene |
|
| Accession: | CHEBI:17356
|
browse the term
|
| Definition: | An ortho-fused polycyclic arene that consists of 9H-fluorene bearing an acetamido substituent at position 2. |
| Synonyms: | exact_synonym: | N-(9H-fluoren-2-yl)acetamide |
| | related_synonym: | 2-AAF; 2-FAA; C15H13NO; CC(=O)Nc1ccc-2c(Cc3ccccc-23)c1; InChI=1S/C15H13NO/c1-10(17)16-13-6-7-15-12(9-13)8-11-4-2-3-5-14(11)15/h2-7,9H,8H2,1H3,(H,16,17); InChIKey=CZIHNRWJTSTCEX-UHFFFAOYSA-N; N-2-Fluorenylacetamide; N-fluoren-2-ylacetamide |
| | alt_id: | CHEBI:11494; CHEBI:19431; CHEBI:40645; CHEBI:981 |
| | xref_casrn: | 53-96-3 |
| | xref: | Beilstein:2807677 "Beilstein Registry Number"; ChEMBL:234083 "ChEMBL COMPOUND"; ChemIDplus:53-96-3 "CAS Registry Number"; KEGG COMPOUND:53-96-3 "CAS Registry Number"; KEGG COMPOUND:C02778 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D015073 |
| | xref: | NIST Chemistry WebBook:53-96-3 "CAS Registry Number"; Reaxys:2807677 "Reaxys Registry Number"; Wikipedia:2-Acetylaminofluorene "Wikipedia" |
|
|
2-acetamidofluorene
|
| G |
Aaas |
achalasia, adrenocortical insufficiency, alacrimia |
|
increases expression |
ISO |
7 |
141,088,006 |
141,107,581 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
EXP |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
decreases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases activity |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
increases expression |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
multiple interactions |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
increases expression |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
multiple interactions |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
increases expression |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
increases expression |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
increases expression |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
increases expression |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases expression |
EXP |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases expression |
EXP |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc10 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 10 |
|
increases expression |
ISO |
9 |
10,219,822 |
10,239,734 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
EXP |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases expression |
EXP |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases expression |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
multiple interactions |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases expression |
EXP |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases expression |
EXP |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
|
multiple interactions |
EXP |
18 |
71,587,259 |
71,632,610 |
RGD:6480464 |
CTD |
| G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
|
decreases expression |
EXP |
13 |
40,547,366 |
40,573,698 |
RGD:6480464 |
CTD |
| G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
|
increases expression |
EXP |
9 |
78,083,239 |
78,106,933 |
RGD:6480464 |
CTD |
| G |
Aen |
apoptosis enhancing nuclease |
|
increases expression |
EXP |
1 |
134,615,998 |
134,625,367 |
RGD:6480464 |
CTD |
| G |
Aen |
apoptosis enhancing nuclease |
|
increases expression |
ISO |
1 |
134,615,998 |
134,625,367 |
RGD:6480464 |
CTD |
| G |
Aen |
apoptosis enhancing nuclease |
|
increases expression |
EXP |
1 |
134,615,998 |
134,625,367 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
increases expression |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
increases expression |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
increases expression |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
multiple interactions |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
multiple interactions |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
increases expression |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
increases expression |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Ak1 |
adenylate kinase 1 |
|
increases expression |
ISO |
2 |
19,821,482 |
19,822,544 |
RGD:6480464 |
CTD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
increases expression |
ISO |
4 |
61,645,438 |
61,659,530 |
RGD:6480464 |
CTD |
| G |
Akr1b10 |
aldo-keto reductase family 1, member B10 (aldose reductase) |
|
multiple interactions |
EXP |
4 |
61,755,871 |
61,771,264 |
RGD:6480464 |
CTD |
| G |
Akr1c12 |
aldo-keto reductase family 1, member C12 |
|
multiple interactions |
EXP |
17 |
77,203,587 |
77,219,705 |
RGD:6480464 |
CTD |
| G |
Akr1c12 |
aldo-keto reductase family 1, member C12 |
|
multiple interactions |
EXP |
17 |
77,203,587 |
77,219,705 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
increases expression |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
|
increases expression |
EXP |
1 |
120,847,746 |
120,881,883 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
multiple interactions |
ISO |
10 |
47,365,195 |
47,374,880 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
EXP |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
EXP |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Anapc11 |
anaphase promoting complex subunit 11 |
|
decreases expression |
EXP |
10 |
109,988,502 |
109,999,500 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
increases expression |
ISO |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
multiple interactions |
EXP |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
multiple interactions |
ISO |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Anxa8 |
annexin A8 |
|
increases expression |
ISO |
16 |
9,715,644 |
9,730,584 |
RGD:6480464 |
CTD |
| G |
Aox1 |
aldehyde oxidase 1 |
|
multiple interactions |
EXP |
9 |
56,693,698 |
56,774,115 |
RGD:6480464 |
CTD |
| G |
Aox1 |
aldehyde oxidase 1 |
|
multiple interactions |
EXP |
9 |
56,693,698 |
56,774,115 |
RGD:6480464 |
CTD |
| G |
Apoa2 |
apolipoprotein A-II |
|
decreases expression |
EXP |
13 |
87,114,734 |
87,116,372 |
RGD:6480464 |
CTD |
| G |
Apoa4 |
apolipoprotein A-IV |
|
decreases expression |
EXP |
8 |
49,233,142 |
49,233,431 |
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Apod |
apolipoprotein D |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Aqp5 |
aquaporin 5 |
|
increases expression |
EXP |
7 |
138,337,725 |
138,341,257 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
increases expression |
ISO |
14 |
18,466,313 |
18,475,571 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
multiple interactions |
ISO |
14 |
18,466,313 |
18,475,571 |
RGD:6480464 |
CTD |
| G |
Asgr1 |
asialoglycoprotein receptor 1 |
|
decreases expression |
EXP |
10 |
56,899,266 |
56,903,173 |
RGD:6480464 |
CTD |
| G |
Atp6v1d |
ATPase, H+ transporting, lysosomal V1 subunit D |
|
increases expression |
EXP |
6 |
101,479,417 |
101,494,826 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
increases expression |
EXP |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
EXP |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Bzw1 |
basic leucine zipper and W2 domains 1 |
|
increases expression |
ISO |
9 |
57,053,423 |
57,065,699 |
RGD:6480464 |
CTD |
| G |
C4bpa |
complement component 4 binding protein, alpha |
|
decreases expression |
EXP |
13 |
43,552,947 |
43,588,565 |
RGD:6480464 |
CTD |
| G |
C6 |
complement component 6 |
|
decreases expression |
EXP |
2 |
53,691,290 |
53,764,539 |
RGD:6480464 |
CTD |
| G |
C7 |
complement component 7 |
|
increases expression |
EXP |
2 |
54,147,136 |
54,250,803 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
multiple interactions |
EXP |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
multiple interactions |
EXP |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
increases expression |
EXP |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cadm1 |
cell adhesion molecule 1 |
|
increases expression |
EXP |
8 |
50,765,645 |
51,108,962 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cblc |
Cbl proto-oncogene, E3 ubiquitin protein ligase C |
|
increases expression |
EXP |
1 |
79,091,412 |
79,108,189 |
RGD:6480464 |
CTD |
| G |
Cbr1 |
carbonyl reductase 1 |
|
increases expression |
ISO |
11 |
33,787,957 |
33,790,320 |
RGD:6480464 |
CTD |
| G |
Cck |
cholecystokinin |
|
decreases expression |
EXP |
8 |
126,492,636 |
126,499,220 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
decreases expression |
EXP |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
EXP |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
EXP |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
increases expression |
EXP |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
increases expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
multiple interactions |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
increases expression |
EXP |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
multiple interactions |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
multiple interactions |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
decreases activity |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
decreases expression |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
ISO |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
ISO |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Cd276 |
Cd276 molecule |
|
increases expression |
EXP |
8 |
62,331,017 |
62,361,346 |
RGD:6480464 |
CTD |
| G |
Cd276 |
Cd276 molecule |
|
increases expression |
EXP |
8 |
62,331,017 |
62,361,346 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
increases expression |
EXP |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
increases expression |
EXP |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cdc37 |
cell division cycle 37 |
|
multiple interactions |
EXP |
8 |
20,164,150 |
20,176,763 |
RGD:6480464 |
CTD |
| G |
Cdca3 |
cell division cycle associated 3 |
|
increases expression |
EXP |
4 |
160,952,986 |
160,956,574 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
increases expression |
EXP |
19 |
48,507,173 |
49,575,123 |
RGD:6480464 |
CTD |
| G |
Cdh22 |
cadherin 22 |
|
increases expression |
EXP |
3 |
156,155,004 |
156,275,540 |
RGD:6480464 |
CTD |
| G |
Cdh3 |
cadherin 3 |
|
increases expression |
EXP |
19 |
36,343,823 |
36,393,819 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
EXP |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases activity |
EXP |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
multiple interactions |
EXP |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
EXP |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
EXP |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases methylation |
EXP |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases methylation |
EXP |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
increases expression |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
increases expression |
EXP |
5 |
131,012,524 |
131,017,679 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
EXP |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
EXP |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
EXP |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
decreases expression |
EXP |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Ces1d |
carboxylesterase 1D |
|
increases expression |
ISO |
19 |
14,928,539 |
14,967,082 |
RGD:6480464 |
CTD |
| G |
Ces2e |
carboxylesterase 2E |
|
increases expression |
ISO |
19 |
65,698 |
82,042 |
RGD:6480464 |
CTD |
| G |
Ces3a |
carboxylesterase 3a |
|
increases expression |
ISO |
19 |
34,929,247 |
34,937,267 |
RGD:6480464 |
CTD |
| G |
Ckmt1b |
creatine kinase, mitochondrial 1B |
|
increases expression |
ISO |
3 |
108,158,887 |
108,163,888 |
RGD:6480464 |
CTD |
| G |
Cldn4 |
claudin 4 |
|
increases expression |
EXP |
12 |
22,816,134 |
22,817,932 |
RGD:6480464 |
CTD |
| G |
Cldn7 |
claudin 7 |
|
increases expression |
EXP |
10 |
56,810,947 |
56,813,134 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
multiple interactions |
EXP |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
multiple interactions |
EXP |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Cmas |
cytidine monophosphate N-acetylneuraminic acid synthetase |
|
increases expression |
EXP |
4 |
180,650,927 |
180,669,243 |
RGD:6480464 |
CTD |
| G |
Col17a1 |
collagen, type XVII, alpha 1 |
|
multiple interactions |
ISO |
1 |
253,012,167 |
253,059,385 |
RGD:6480464 |
CTD |
| G |
Commd3 |
COMM domain containing 3 |
|
increases expression |
ISO |
17 |
92,775,474 |
92,779,187 |
RGD:6480464 |
CTD |
| G |
Coq6 |
coenzyme Q6 homolog, monooxygenase (S. cerevisiae) |
|
multiple interactions |
EXP |
6 |
108,425,610 |
108,436,950 |
RGD:6480464 |
CTD |
| G |
Cpq |
carboxypeptidase Q |
|
decreases expression |
EXP |
7 |
68,430,069 |
68,900,500 |
RGD:6480464 |
CTD |
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
multiple interactions |
EXP |
9 |
65,907,211 |
66,017,942 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
increases expression |
EXP |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Cryl1 |
crystallin, lambda 1 |
|
multiple interactions |
EXP |
15 |
36,320,075 |
36,440,579 |
RGD:6480464 |
CTD |
| G |
Cryl1 |
crystallin, lambda 1 |
|
multiple interactions |
EXP |
15 |
36,320,075 |
36,440,579 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
increases expression |
EXP |
19 |
10,666,940 |
10,676,424 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
multiple interactions |
EXP |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
increases expression |
EXP |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
EXP |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
multiple interactions |
EXP |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases hydrolysis |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases hydrolysis |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases activity |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
decreases expression |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
decreases expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2c13 |
cytochrome P450, family 2, subfamily c, polypeptide 13 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
increases expression |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
multiple interactions |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
multiple interactions |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
multiple interactions |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp4f4 |
cytochrome P450, family 4, subfamily f, polypeptide 4 |
|
multiple interactions |
ISO |
7 |
13,293,080 |
13,309,416 |
RGD:6480464 |
CTD |
| G |
Cyp4f5 |
cytochrome P450, family 4, subfamily f, polypeptide 5 |
|
increases expression |
EXP |
7 |
13,119,551 |
13,134,015 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Dap |
death-associated protein |
|
multiple interactions |
EXP |
2 |
83,281,937 |
83,335,284 |
RGD:6480464 |
CTD |
| G |
Dap |
death-associated protein |
|
multiple interactions |
EXP |
2 |
83,281,937 |
83,335,284 |
RGD:6480464 |
CTD |
| G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
|
increases expression |
EXP |
2 |
243,932,221 |
244,069,832 |
RGD:6480464 |
CTD |
| G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
|
increases expression |
ISO |
2 |
51,881,101 |
51,881,461 |
RGD:6480464 |
CTD |
| G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
increases expression |
EXP |
20 |
3,194,265 |
3,214,611 |
RGD:6480464 |
CTD |
| G |
Des |
desmin |
|
increases expression |
EXP |
9 |
74,637,783 |
74,645,499 |
RGD:6480464 |
CTD |
| G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
|
decreases activity |
EXP |
19 |
39,463,111 |
39,477,184 |
RGD:6480464 |
CTD |
| G |
Dlk1 |
delta-like 1 homolog (Drosophila) |
|
increases expression |
EXP |
6 |
134,022,016 |
134,043,058 |
RGD:6480464 |
CTD |
| G |
Dlk1 |
delta-like 1 homolog (Drosophila) |
|
increases expression |
EXP |
6 |
134,022,016 |
134,043,058 |
RGD:6480464 |
CTD |
| G |
Dlk1 |
delta-like 1 homolog (Drosophila) |
|
increases expression |
EXP |
6 |
134,022,016 |
134,043,058 |
RGD:6480464 |
CTD |
| G |
Dlk1 |
delta-like 1 homolog (Drosophila) |
|
increases expression |
EXP |
6 |
134,022,016 |
134,043,058 |
RGD:6480464 |
CTD |
| G |
Dlk1 |
delta-like 1 homolog (Drosophila) |
|
increases expression |
EXP |
6 |
134,022,016 |
134,043,058 |
RGD:6480464 |
CTD |
| G |
Dlk1 |
delta-like 1 homolog (Drosophila) |
|
increases expression |
EXP |
6 |
134,022,016 |
134,043,058 |
RGD:6480464 |
CTD |
| G |
Dmp1 |
dentin matrix acidic phosphoprotein 1 |
|
increases expression |
ISO |
14 |
6,637,127 |
6,644,100 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
increases expression |
EXP |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
decreases expression |
EXP |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
E2f3 |
E2F transcription factor 3 |
|
decreases expression |
EXP |
17 |
41,079,346 |
41,145,568 |
RGD:6480464 |
CTD |
| G |
E2f3 |
E2F transcription factor 3 |
|
decreases expression |
EXP |
17 |
41,079,346 |
41,145,568 |
RGD:6480464 |
CTD |
| G |
E2f4 |
E2F transcription factor 4, p107/p130-binding |
|
decreases expression |
EXP |
19 |
35,112,273 |
35,118,888 |
RGD:6480464 |
CTD |
| G |
Eda2r |
ectodysplasin A2 receptor |
|
increases expression |
ISO |
X |
85,010,195 |
85,049,670 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
decreases localization |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
EXP |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Ei24 |
etoposide induced 2.4 |
|
multiple interactions |
ISO |
8 |
38,028,043 |
38,044,316 |
RGD:6480464 |
CTD |
| G |
Emp2 |
epithelial membrane protein 2 |
|
increases expression |
ISO |
10 |
5,311,157 |
5,348,038 |
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
increases expression |
ISO |
2 |
27,720,805 |
27,733,168 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
multiple interactions |
EXP |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
multiple interactions |
EXP |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Epcam |
epithelial cell adhesion molecule |
|
increases expression |
EXP |
6 |
11,176,664 |
11,192,628 |
RGD:6480464 |
CTD |
| G |
Epcam |
epithelial cell adhesion molecule |
|
increases expression |
EXP |
6 |
11,176,664 |
11,192,628 |
RGD:6480464 |
CTD |
| G |
Epha1 |
Eph receptor A1 |
|
increases expression |
ISO |
4 |
70,127,872 |
70,142,309 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
ISO |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
ISO |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
increases expression |
EXP |
10 |
87,219,157 |
87,242,919 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Exoc4 |
exocyst complex component 4 |
|
increases expression |
ISO |
4 |
60,406,942 |
61,284,294 |
RGD:6480464 |
CTD |
| G |
Fam110a |
family with sequence similarity 110, member A |
|
increases expression |
ISO |
3 |
142,326,013 |
142,328,572 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fbxw9 |
F-box and WD repeat domain containing 9 |
|
increases expression |
ISO |
19 |
24,746,820 |
24,753,726 |
RGD:6480464 |
CTD |
| G |
Fhit |
fragile histidine triad |
|
decreases expression |
EXP |
15 |
15,823,461 |
17,329,184 |
RGD:6480464 |
CTD |
| G |
Flt3 |
fms-related tyrosine kinase 3 |
|
affects expression |
EXP |
12 |
8,193,629 |
8,268,682 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
decreases expression |
EXP |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
multiple interactions |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
Gaa |
glucosidase, alpha, acid |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gas2l3 |
growth arrest-specific 2 like 3 |
|
decreases expression |
ISO |
7 |
26,150,699 |
26,170,382 |
RGD:6480464 |
CTD |
| G |
Gcgr |
glucagon receptor |
|
multiple interactions |
EXP |
10 |
109,921,411 |
109,929,577 |
RGD:6480464 |
CTD |
| G |
Gcgr |
glucagon receptor |
|
multiple interactions |
EXP |
10 |
109,921,411 |
109,929,577 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
EXP |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
EXP |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
multiple interactions |
EXP |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
decreases expression |
EXP |
X |
89,448,873 |
89,456,812 |
RGD:6480464 |
CTD |
| G |
Glrx3 |
glutaredoxin 3 |
|
increases expression |
ISO |
1 |
197,176,020 |
197,206,249 |
RGD:6480464 |
CTD |
| G |
Gpc3 |
glypican 3 |
|
increases expression |
EXP |
X |
139,192,115 |
139,560,649 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
EXP |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
EXP |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gria3 |
glutamate receptor, ionotropic, AMPA 3 |
|
increases expression |
EXP |
X |
3,452,523 |
3,718,486 |
RGD:6480464 |
CTD |
| G |
Gria3 |
glutamate receptor, ionotropic, AMPA 3 |
|
increases expression |
ISO |
X |
3,452,523 |
3,718,486 |
RGD:6480464 |
CTD |
| G |
Grina |
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
|
increases expression |
ISO |
7 |
114,277,208 |
114,280,339 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
increases expression |
ISO |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
increases expression |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
ISO |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
multiple interactions |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
multiple interactions |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gtse1 |
G-2 and S-phase expressed 1 |
|
increases expression |
ISO |
7 |
123,862,066 |
123,878,554 |
RGD:6480464 |
CTD |
| G |
Hadha |
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit |
|
multiple interactions |
EXP |
6 |
26,173,798 |
26,191,433 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
multiple interactions |
EXP |
1 |
85,978,120 |
85,980,059 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
decreases expression |
EXP |
1 |
85,978,120 |
85,980,059 |
RGD:6480464 |
CTD |
| G |
Hebp2 |
heme binding protein 2 |
|
multiple interactions |
ISO |
1 |
13,628,658 |
13,635,958 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
decreases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
increases expression |
EXP |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hsd17b6 |
hydroxysteroid (17-beta) dehydrogenase 6 |
|
decreases expression |
EXP |
7 |
1,118,183 |
1,137,670 |
RGD:6480464 |
CTD |
| G |
Ica1 |
islet cell autoantigen 1 |
|
increases expression |
EXP |
4 |
33,680,878 |
33,830,443 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
increases expression |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Ifna1 |
interferon, alpha 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igfals |
insulin-like growth factor binding protein, acid labile subunit |
|
decreases expression |
ISO |
10 |
14,127,416 |
14,130,662 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
increases activity |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
increases expression |
EXP |
17 |
78,050,491 |
78,097,802 |
RGD:6480464 |
CTD |
| G |
Il33 |
interleukin 33 |
|
increases expression |
ISO |
1 |
233,670,801 |
233,685,798 |
RGD:6480464 |
CTD |
| G |
Itgb4 |
integrin, beta 4 |
|
increases expression |
ISO |
10 |
106,080,452 |
106,116,632 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kif11 |
kinesin family member 11 |
|
increases expression |
EXP |
1 |
241,668,938 |
241,722,847 |
RGD:6480464 |
CTD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
increases expression |
EXP |
14 |
34,906,043 |
34,984,819 |
RGD:6480464 |
CTD |
| G |
Krt15 |
keratin 15 |
|
increases expression |
ISO |
10 |
89,071,915 |
89,075,732 |
RGD:6480464 |
CTD |
| G |
Krt15 |
keratin 15 |
|
multiple interactions |
ISO |
10 |
89,071,915 |
89,075,732 |
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
increases expression |
EXP |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
increases expression |
EXP |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
multiple interactions |
EXP |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt20 |
keratin 20 |
|
decreases expression |
ISO |
10 |
88,335,894 |
88,379,899 |
RGD:6480464 |
CTD |
| G |
Krt23 |
keratin 23 (histone deacetylase inducible) |
|
multiple interactions |
ISO |
10 |
88,420,780 |
88,436,791 |
RGD:6480464 |
CTD |
| G |
Krt23 |
keratin 23 (histone deacetylase inducible) |
|
increases expression |
ISO |
10 |
88,420,780 |
88,436,791 |
RGD:6480464 |
CTD |
| G |
Krt4 |
keratin 4 |
|
increases expression |
ISO |
7 |
140,622,632 |
140,628,079 |
RGD:6480464 |
CTD |
| G |
Krt4 |
keratin 4 |
|
multiple interactions |
ISO |
7 |
140,622,632 |
140,628,079 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
multiple interactions |
EXP |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
multiple interactions |
EXP |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Lig4 |
ligase IV, DNA, ATP-dependent |
|
decreases expression |
EXP |
16 |
84,881,880 |
84,888,448 |
RGD:6480464 |
CTD |
| G |
LOC100361349 |
hypothetical protein LOC100361349 |
|
increases expression |
ISO |
2 |
185,155,651 |
185,161,067 |
RGD:6480464 |
CTD |
| G |
LOC100361349 |
hypothetical protein LOC100361349 |
|
multiple interactions |
ISO |
2 |
185,155,651 |
185,161,067 |
RGD:6480464 |
CTD |
| G |
Ly6d |
lymphocyte antigen 6 complex, locus D |
|
increases expression |
ISO |
7 |
112,872,991 |
112,874,499 |
RGD:6480464 |
CTD |
| G |
Ly6e |
lymphocyte antigen 6 complex, locus E |
|
increases expression |
ISO |
7 |
113,151,828 |
113,155,521 |
RGD:6480464 |
CTD |
| G |
Lypd3 |
Ly6/Plaur domain containing 3 |
|
multiple interactions |
ISO |
1 |
79,917,952 |
79,922,402 |
RGD:6480464 |
CTD |
| G |
Lzic |
leucine zipper and CTNNBIP1 domain containing |
|
increases expression |
ISO |
5 |
166,567,412 |
166,579,423 |
RGD:6480464 |
CTD |
| G |
Mal |
mal, T-cell differentiation protein |
|
increases expression |
ISO |
3 |
115,166,671 |
115,190,432 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Matn2 |
matrilin 2 |
|
increases expression |
EXP |
7 |
69,715,611 |
69,880,723 |
RGD:6480464 |
CTD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
increases expression |
ISO |
1 |
233,978,931 |
233,983,824 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
EXP |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
multiple interactions |
EXP |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
EXP |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
increases expression |
EXP |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgst2 |
microsomal glutathione S-transferase 2 |
|
multiple interactions |
EXP |
2 |
140,546,939 |
140,568,616 |
RGD:6480464 |
CTD |
| G |
Mgst2 |
microsomal glutathione S-transferase 2 |
|
multiple interactions |
EXP |
2 |
140,546,939 |
140,568,616 |
RGD:6480464 |
CTD |
| G |
Mir17-1 |
microRNA mir-17-1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
multiple interactions |
EXP |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
increases expression |
EXP |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
multiple interactions |
EXP |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
increases expression |
ISO |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
increases expression |
EXP |
2 |
181,399,482 |
181,403,640 |
RGD:6480464 |
CTD |
| G |
Mybl1 |
myeloblastosis oncogene-like 1 |
|
increases expression |
ISO |
5 |
9,136,980 |
9,170,799 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases mutagenesis |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
decreases expression |
EXP |
6 |
51,129,160 |
51,166,514 |
RGD:6480464 |
CTD |
| G |
Nat1 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
increases activity |
ISO |
16 |
23,845,894 |
23,876,528 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
increases activity |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nek6 |
NIMA-related kinase 6 |
|
increases expression |
EXP |
3 |
18,348,698 |
18,381,895 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases localization |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
multiple interactions |
EXP |
1 |
83,865,440 |
83,873,010 |
RGD:6480464 |
CTD |
| G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
increases degradation |
EXP |
1 |
83,865,440 |
83,873,010 |
RGD:6480464 |
CTD |
| G |
Ninj1 |
ninjurin 1 |
|
multiple interactions |
EXP |
17 |
21,410,701 |
21,419,472 |
RGD:6480464 |
CTD |
| G |
Ninj1 |
ninjurin 1 |
|
multiple interactions |
EXP |
17 |
21,410,701 |
21,419,472 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Notch1 |
notch 1 |
|
increases expression |
ISO |
3 |
4,631,797 |
4,677,640 |
RGD:6480464 |
CTD |
| G |
Nprl2 |
nitrogen permease regulator-like 2 (S. cerevisiae) |
|
increases expression |
ISO |
8 |
112,789,664 |
112,792,837 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases expression |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases expression |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases expression |
EXP |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
EXP |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nudcd2 |
NudC domain containing 2 |
|
increases expression |
ISO |
10 |
25,763,129 |
25,768,887 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein, transcriptional regulator, 1 |
|
decreases expression |
EXP |
1 |
185,770,310 |
185,772,313 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein, transcriptional regulator, 1 |
|
decreases expression |
EXP |
1 |
185,770,310 |
185,772,313 |
RGD:6480464 |
CTD |
| G |
Nusap1 |
nucleolar and spindle associated protein 1 |
|
increases expression |
EXP |
3 |
106,134,200 |
106,165,155 |
RGD:6480464 |
CTD |
| G |
Ociad2 |
OCIA domain containing 2 |
|
increases expression |
ISO |
14 |
37,273,819 |
37,292,695 |
RGD:6480464 |
CTD |
| G |
Olfm1 |
olfactomedin 1 |
|
increases expression |
ISO |
3 |
7,170,421 |
7,195,345 |
RGD:6480464 |
CTD |
| G |
Olr37 |
olfactory receptor 37 |
|
decreases expression |
EXP |
1 |
157,123,043 |
157,124,008 |
RGD:6480464 |
CTD |
| G |
Osm |
oncostatin M |
|
increases expression |
EXP |
14 |
84,857,232 |
84,860,082 |
RGD:6480464 |
CTD |
| G |
Osm |
oncostatin M |
|
increases expression |
EXP |
14 |
84,857,232 |
84,860,082 |
RGD:6480464 |
CTD |
| G |
Osmr |
oncostatin M receptor |
|
increases expression |
EXP |
2 |
56,080,700 |
56,121,463 |
RGD:6480464 |
CTD |
| G |
Padi2 |
peptidyl arginine deiminase, type II |
|
multiple interactions |
ISO |
5 |
159,762,824 |
159,805,399 |
RGD:6480464 |
CTD |
| G |
Pbsn |
probasin |
|
increases expression |
EXP |
X |
63,581,742 |
63,597,497 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
decreases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
|
multiple interactions |
EXP |
3 |
108,216,414 |
108,240,138 |
RGD:6480464 |
CTD |
| G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
|
multiple interactions |
EXP |
3 |
108,216,414 |
108,240,138 |
RGD:6480464 |
CTD |
| G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
increases expression |
EXP |
10 |
96,056,220 |
96,057,232 |
RGD:6480464 |
CTD |
| G |
Perp |
PERP, TP53 apoptosis effector |
|
multiple interactions |
ISO |
1 |
13,976,356 |
13,988,803 |
RGD:6480464 |
CTD |
| G |
Phlda3 |
pleckstrin homology-like domain, family A, member 3 |
|
increases expression |
EXP |
13 |
48,789,678 |
48,793,999 |
RGD:6480464 |
CTD |
| G |
Phlda3 |
pleckstrin homology-like domain, family A, member 3 |
|
increases expression |
ISO |
13 |
48,789,678 |
48,793,999 |
RGD:6480464 |
CTD |
| G |
Phlda3 |
pleckstrin homology-like domain, family A, member 3 |
|
increases expression |
EXP |
13 |
48,789,678 |
48,793,999 |
RGD:6480464 |
CTD |
| G |
Phyh |
phytanoyl-CoA 2-hydroxylase |
|
multiple interactions |
EXP |
17 |
84,418,173 |
84,435,073 |
RGD:6480464 |
CTD |
| G |
Phyh |
phytanoyl-CoA 2-hydroxylase |
|
multiple interactions |
EXP |
17 |
84,418,173 |
84,435,073 |
RGD:6480464 |
CTD |
| G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
increases mutagenesis |
EXP |
X |
50,797,413 |
50,812,217 |
RGD:6480464 |
CTD |
| G |
Pkd1 |
polycystic kidney disease 1 homolog (human) |
|
decreases expression |
EXP |
10 |
13,801,445 |
13,848,212 |
RGD:6480464 |
CTD |
| G |
Pkm |
pyruvate kinase, muscle |
|
increases expression |
EXP |
8 |
63,486,492 |
63,508,016 |
RGD:6480464 |
CTD |
| G |
Pkp1 |
plakophilin 1 |
|
increases expression |
ISO |
13 |
48,910,028 |
48,958,983 |
RGD:6480464 |
CTD |
| G |
Plk2 |
polo-like kinase 2 |
|
increases expression |
ISO |
2 |
41,800,745 |
41,806,503 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
EXP |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
multiple interactions |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Polk |
polymerase (DNA directed) kappa |
|
increases expression |
ISO |
2 |
26,952,022 |
27,012,088 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases expression |
EXP |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Prc1 |
protein regulator of cytokinesis 1 |
|
increases expression |
EXP |
1 |
136,112,674 |
136,133,720 |
RGD:6480464 |
CTD |
| G |
Prkcdbp |
protein kinase C, delta binding protein |
|
multiple interactions |
EXP |
1 |
163,212,922 |
163,214,511 |
RGD:6480464 |
CTD |
| G |
Prkch |
protein kinase C, eta |
|
multiple interactions |
EXP |
6 |
96,069,354 |
96,281,790 |
RGD:6480464 |
CTD |
| G |
Prkch |
protein kinase C, eta |
|
multiple interactions |
EXP |
6 |
96,069,354 |
96,281,790 |
RGD:6480464 |
CTD |
| G |
Prom1 |
prominin 1 |
|
increases expression |
EXP |
14 |
72,122,986 |
72,230,453 |
RGD:6480464 |
CTD |
| G |
Psmd10 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Psmd10 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Psrc1 |
proline/serine-rich coiled-coil 1 |
|
increases expression |
ISO |
2 |
203,952,299 |
203,956,742 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
decreases expression |
EXP |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Ptgr1 |
prostaglandin reductase 1 |
|
multiple interactions |
EXP |
5 |
77,010,809 |
77,029,326 |
RGD:6480464 |
CTD |
| G |
Ptn |
pleiotrophin |
|
increases expression |
EXP |
4 |
64,078,755 |
64,160,135 |
RGD:6480464 |
CTD |
| G |
Ptp4a3 |
protein tyrosine phosphatase type IVA, member 3 |
|
increases expression |
ISO |
7 |
111,462,191 |
111,468,045 |
RGD:6480464 |
CTD |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
increases expression |
EXP |
13 |
51,246,163 |
51,357,995 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
increases expression |
EXP |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
increases activity |
ISO |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
multiple interactions |
ISO |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Rassf1 |
Ras association (RalGDS/AF-6) domain family member 1 |
|
increases methylation |
EXP |
8 |
112,798,863 |
112,810,004 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
affects phosphorylation |
EXP |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
EXP |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
EXP |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rbx1 |
ring-box 1, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
7 |
119,794,976 |
119,805,104 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases localization |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
RGD1308114 |
similar to cDNA sequence AF397014 |
|
decreases expression |
EXP |
17 |
55,271,485 |
56,354,931 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin (senescence marker protein-30) |
|
multiple interactions |
EXP |
X |
13,037,171 |
13,052,846 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin (senescence marker protein-30) |
|
multiple interactions |
EXP |
X |
13,037,171 |
13,052,846 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
increases expression |
EXP |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rhob |
ras homolog family member B |
|
increases expression |
EXP |
6 |
32,052,333 |
32,054,507 |
RGD:6480464 |
CTD |
| G |
Rhobtb2 |
Rho-related BTB domain containing 2 |
|
increases expression |
EXP |
15 |
50,166,160 |
50,184,221 |
RGD:6480464 |
CTD |
| G |
Ripk1 |
receptor (TNFRSF)-interacting serine-threonine kinase 1 |
|
decreases expression |
EXP |
17 |
37,183,591 |
37,216,533 |
RGD:6480464 |
CTD |
| G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
|
increases expression |
ISO |
15 |
33,947,406 |
33,956,351 |
RGD:6480464 |
CTD |
| G |
Ripk4 |
receptor-interacting serine-threonine kinase 4 |
|
increases expression |
ISO |
11 |
37,767,796 |
37,790,029 |
RGD:6480464 |
CTD |
| G |
Ros1 |
c-ros oncogene 1 , receptor tyrosine kinase |
|
increases expression |
EXP |
20 |
30,755,101 |
30,910,604 |
RGD:6480464 |
CTD |
| G |
Rprm |
reprimo, TP53 dependent G2 arrest mediator candidate |
|
decreases expression |
EXP |
3 |
35,590,166 |
35,591,583 |
RGD:6480464 |
CTD |
| G |
Rprm |
reprimo, TP53 dependent G2 arrest mediator candidate |
|
multiple interactions |
ISO |
3 |
35,590,166 |
35,591,583 |
RGD:6480464 |
CTD |
| G |
Rprm |
reprimo, TP53 dependent G2 arrest mediator candidate |
|
increases expression |
EXP |
3 |
35,590,166 |
35,591,583 |
RGD:6480464 |
CTD |
| G |
Rps27l |
ribosomal protein S27-like |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rps27l |
ribosomal protein S27-like |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rps27l2 |
ribosomal protein S27-like 2 |
|
increases expression |
ISO |
12 |
29,143,461 |
29,143,842 |
RGD:6480464 |
CTD |
| G |
Rrm1-ps1 |
ribonucleotide reductase M1, pseudogene 1 |
|
increases expression |
ISO |
14 |
77,408,781 |
77,411,150 |
RGD:6480464 |
CTD |
| G |
Rrm2b |
ribonucleotide reductase M2 B (TP53 inducible) |
|
increases expression |
ISO |
7 |
73,432,161 |
73,459,541 |
RGD:6480464 |
CTD |
| G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
|
decreases expression |
ISO |
6 |
44,100,775 |
44,113,910 |
RGD:6480464 |
CTD |
| G |
S100a11 |
S100 calcium binding protein A11 |
|
increases expression |
ISO |
2 |
186,620,360 |
186,621,911 |
RGD:6480464 |
CTD |
| G |
Scarb2 |
scavenger receptor class B, member 2 |
|
increases expression |
ISO |
14 |
17,119,366 |
17,170,850 |
RGD:6480464 |
CTD |
| G |
Scpep1 |
serine carboxypeptidase 1 |
|
multiple interactions |
EXP |
10 |
77,347,473 |
77,377,945 |
RGD:6480464 |
CTD |
| G |
Scpep1 |
serine carboxypeptidase 1 |
|
multiple interactions |
EXP |
10 |
77,347,473 |
77,377,945 |
RGD:6480464 |
CTD |
| G |
Sctr |
secretin receptor |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Serpina7 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 |
|
increases expression |
EXP |
X |
126,739,203 |
126,744,763 |
RGD:6480464 |
CTD |
| G |
Serpinb5 |
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
|
increases expression |
ISO |
13 |
13,037,587 |
13,057,785 |
RGD:6480464 |
CTD |
| G |
Serpinb5 |
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
|
multiple interactions |
ISO |
13 |
13,037,587 |
13,057,785 |
RGD:6480464 |
CTD |
| G |
Serpinf1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
|
decreases expression |
ISO |
10 |
62,713,441 |
62,739,444 |
RGD:6480464 |
CTD |
| G |
Sesn2 |
sestrin 2 |
|
increases expression |
ISO |
5 |
152,639,951 |
152,655,828 |
RGD:6480464 |
CTD |
| G |
Sfn |
stratifin |
|
increases expression |
EXP |
5 |
151,475,395 |
151,479,996 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
increases expression |
EXP |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Slc15a5 |
solute carrier family 15, member 5 |
|
decreases expression |
ISO |
4 |
175,098,364 |
175,191,369 |
RGD:6480464 |
CTD |
| G |
Slc16a10 |
solute carrier family 16, member 10 (aromatic amino acid transporter) |
|
decreases expression |
EXP |
20 |
44,211,651 |
44,325,332 |
RGD:6480464 |
CTD |
| G |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
|
multiple interactions |
ISO |
16 |
49,353,476 |
49,357,271 |
RGD:6480464 |
CTD |
| G |
Slc2a8 |
solute carrier family 2, (facilitated glucose transporter) member 8 |
|
multiple interactions |
ISO |
3 |
11,962,570 |
11,972,115 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
increases expression |
EXP |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
multiple interactions |
EXP |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
multiple interactions |
EXP |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Smad2 |
SMAD family member 2 |
|
multiple interactions |
EXP |
18 |
73,180,520 |
73,241,707 |
RGD:6480464 |
CTD |
| G |
Smad3 |
SMAD family member 3 |
|
multiple interactions |
EXP |
8 |
67,803,909 |
67,952,056 |
RGD:6480464 |
CTD |
| G |
Smo |
smoothened, frizzled family receptor |
|
increases expression |
EXP |
4 |
56,623,494 |
56,645,571 |
RGD:6480464 |
CTD |
| G |
Sntg2 |
syntrophin, gamma 2 |
|
decreases expression |
ISO |
6 |
48,059,246 |
48,263,991 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sox4 |
SRY (sex determining region Y)-box 4 |
|
increases expression |
EXP |
17 |
42,172,863 |
42,177,590 |
RGD:6480464 |
CTD |
| G |
Spg7 |
spastic paraplegia 7 homolog (human) |
|
multiple interactions |
EXP |
19 |
53,400,904 |
53,433,742 |
RGD:6480464 |
CTD |
| G |
Spg7 |
spastic paraplegia 7 homolog (human) |
|
multiple interactions |
EXP |
19 |
53,400,904 |
53,433,742 |
RGD:6480464 |
CTD |
| G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
|
decreases expression |
EXP |
18 |
37,090,934 |
37,099,835 |
RGD:6480464 |
CTD |
| G |
Sprr1a |
small proline-rich protein 1A |
|
increases expression |
ISO |
2 |
185,463,951 |
185,465,849 |
RGD:6480464 |
CTD |
| G |
Sptlc2 |
serine palmitoyltransferase, long chain base subunit 2 |
|
increases expression |
ISO |
6 |
111,546,037 |
111,622,959 |
RGD:6480464 |
CTD |
| G |
Sst |
somatostatin |
|
increases expression |
EXP |
11 |
79,125,031 |
79,126,216 |
RGD:6480464 |
CTD |
| G |
St3gal3 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
|
decreases expression |
ISO |
5 |
138,397,472 |
138,599,287 |
RGD:6480464 |
CTD |
| G |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
|
increases expression |
EXP |
4 |
105,373,385 |
105,432,192 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
EXP |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Steap3 |
STEAP family member 3, metalloreductase |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
increases expression |
EXP |
5 |
153,226,420 |
153,232,084 |
RGD:6480464 |
CTD |
| G |
Sulf2 |
sulfatase 2 |
|
increases expression |
EXP |
3 |
157,197,256 |
157,298,389 |
RGD:6480464 |
CTD |
| G |
Sulf2 |
sulfatase 2 |
|
increases expression |
ISO |
3 |
157,197,256 |
157,298,389 |
RGD:6480464 |
CTD |
| G |
Sult1c2 |
sulfotransferase family, cytosolic, 1C, member 2 |
|
decreases expression |
ISO |
9 |
972,522 |
998,125 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, estrogen-preferring, member 1 |
|
multiple interactions |
EXP |
14 |
21,948,475 |
21,965,541 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, estrogen-preferring, member 1 |
|
multiple interactions |
EXP |
14 |
21,948,475 |
21,965,541 |
RGD:6480464 |
CTD |
| G |
Sult2a1 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 |
|
decreases expression |
EXP |
1 |
75,632,632 |
75,708,022 |
RGD:6480464 |
CTD |
| G |
Taldo1 |
transaldolase 1 |
|
multiple interactions |
EXP |
1 |
201,582,856 |
201,593,187 |
RGD:6480464 |
CTD |
| G |
Taldo1 |
transaldolase 1 |
|
multiple interactions |
EXP |
1 |
201,582,856 |
201,593,187 |
RGD:6480464 |
CTD |
| G |
Tes |
testis derived transcript |
|
increases expression |
EXP |
4 |
42,680,722 |
42,719,246 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
decreases expression |
EXP |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
multiple interactions |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Thy1 |
Thy-1 cell surface antigen |
|
increases expression |
EXP |
8 |
47,027,721 |
47,031,857 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Tkt |
transketolase |
|
multiple interactions |
EXP |
16 |
5,908,759 |
5,933,695 |
RGD:6480464 |
CTD |
| G |
Tkt |
transketolase |
|
multiple interactions |
EXP |
16 |
5,908,759 |
5,933,695 |
RGD:6480464 |
CTD |
| G |
Tmem134 |
transmembrane protein 134 |
|
increases expression |
ISO |
1 |
206,708,930 |
206,714,409 |
RGD:6480464 |
CTD |
| G |
Tmem184c |
transmembrane protein 184C |
|
increases expression |
EXP |
19 |
32,158,361 |
32,174,009 |
RGD:6480464 |
CTD |
| G |
Tmem43 |
transmembrane protein 43 |
|
increases expression |
ISO |
4 |
125,656,685 |
125,671,827 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
increases expression |
EXP |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
|
multiple interactions |
EXP |
5 |
25,008,253 |
25,014,263 |
RGD:6480464 |
CTD |
| G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
|
multiple interactions |
EXP |
5 |
25,008,253 |
25,014,263 |
RGD:6480464 |
CTD |
| G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
|
increases expression |
ISO |
5 |
25,008,253 |
25,014,263 |
RGD:6480464 |
CTD |
| G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
|
increases expression |
EXP |
5 |
25,008,253 |
25,014,263 |
RGD:6480464 |
CTD |
| G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
multiple interactions |
EXP |
20 |
11,053,301 |
11,099,740 |
RGD:6480464 |
CTD |
| G |
Tshb |
thyroid stimulating hormone, beta |
|
multiple interactions |
ISO |
2 |
197,908,308 |
197,913,186 |
RGD:6480464 |
CTD |
| G |
Ttr |
transthyretin |
|
multiple interactions |
ISO |
18 |
12,406,571 |
12,413,680 |
RGD:6480464 |
CTD |
| G |
Tubb4b |
tubulin, beta 4B class IVb |
|
increases expression |
ISO |
3 |
3,387,050 |
3,389,500 |
RGD:6480464 |
CTD |
| G |
Tubb6 |
tubulin, beta 6 class V |
|
increases expression |
ISO |
18 |
63,919,776 |
63,929,415 |
RGD:6480464 |
CTD |
| G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
|
increases expression |
ISO |
3 |
155,800,357 |
155,802,757 |
RGD:6480464 |
CTD |
| G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
|
multiple interactions |
ISO |
3 |
155,800,357 |
155,802,757 |
RGD:6480464 |
CTD |
| G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
|
increases expression |
EXP |
3 |
155,800,357 |
155,802,757 |
RGD:6480464 |
CTD |
| G |
Ugt1a8 |
UDP glycosyltransferase 1 family, polypeptide A8 |
|
increases glucuronidation |
ISO |
9 |
87,017,029 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
increases glucuronidation |
ISO |
9 |
86,986,915 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Wbp5 |
WW domain binding protein 5 |
|
multiple interactions |
EXP |
X |
123,554,560 |
123,556,844 |
RGD:6480464 |
CTD |
| G |
Wbp5 |
WW domain binding protein 5 |
|
multiple interactions |
EXP |
X |
123,554,560 |
123,556,844 |
RGD:6480464 |
CTD |
| G |
Wee1 |
wee 1 homolog (S. pombe) |
|
increases expression |
EXP |
1 |
167,769,797 |
167,788,199 |
RGD:6480464 |
CTD |
| G |
Wfdc15b |
WAP four-disulfide core domain 15B |
|
decreases expression |
ISO |
3 |
155,159,854 |
155,160,238 |
RGD:6480464 |
CTD |
| G |
Wwox |
WW domain-containing oxidoreductase |
|
decreases expression |
ISO |
19 |
44,516,391 |
44,829,849 |
RGD:6480464 |
CTD |
| G |
Xpc |
xeroderma pigmentosum, complementation group C |
|
decreases response to substance |
ISO |
4 |
125,672,674 |
125,699,925 |
RGD:6480464 |
CTD |
| G |
Zeb1 |
zinc finger E-box binding homeobox 1 |
|
decreases expression |
EXP |
17 |
60,177,150 |
60,198,584 |
RGD:6480464 |
CTD |
| G |
Zeb2 |
zinc finger E-box binding homeobox 2 |
|
decreases expression |
EXP |
3 |
25,513,009 |
25,654,964 |
RGD:6480464 |
CTD |
| G |
Zmat3 |
zinc finger, matrin type 3 |
|
increases expression |
EXP |
2 |
118,526,985 |
118,537,727 |
RGD:6480464 |
CTD |
| G |
Zmat3 |
zinc finger, matrin type 3 |
|
increases expression |
EXP |
2 |
118,526,985 |
118,537,727 |
RGD:6480464 |
CTD |
| G |
Zmat3 |
zinc finger, matrin type 3 |
|
multiple interactions |
ISO |
2 |
118,526,985 |
118,537,727 |
RGD:6480464 |
CTD |
| G |
Zmat3 |
zinc finger, matrin type 3 |
|
increases expression |
ISO |
2 |
118,526,985 |
118,537,727 |
RGD:6480464 |
CTD |
| G |
Zmat3 |
zinc finger, matrin type 3 |
|
increases expression |
ISO |
2 |
118,526,985 |
118,537,727 |
RGD:6480464 |
CTD |
| G |
Zmat3 |
zinc finger, matrin type 3 |
|
increases expression |
EXP |
2 |
118,526,985 |
118,537,727 |
RGD:6480464 |
CTD |
Term paths to the root
|